Hospital & Healthcare

DCDC Kidney Care Expands Affordable Dialysis Access with Faridabad Launch

15-machine centre aims to address rising demand for renal care services...

The New Backbone of Hospitals: Why Diagnostics is Driving Healthcare Transformation

The transformation of modern diagnostics is being driven not only by artificial intelligence and data integration, but also by the rapid evolution of imaging technologies such as MRI and CT systems...

AMR Innovation Needs New Investment Models to Match Growing Global Health Needs

Investment manager Michael Lamprecht highlights structural funding gaps, regulatory fragmentation, and the need for commercially viable antimicrobial resistance strategies ...

Neurolief to Showcase At-Home Brain Stimulation Therapy for Major Depressive Disorder at APA 2026

The company will present Proliv Rx, its FDA-approved physician-directed neuromodulation therapy for adults with major depressive disorder who have not responded adequately to antidepressant medication. ...

Caracal’s Strata Glove Receives Greenhealth Approved Seal

The recognition places Caracal’s nitrile examination glove within a vetted category of medical products meeting sustainability and safer chemical criteria for healthcare procurement. ...

From Chinese medicine to computing: Duke-NUS broadens access to medicine

Expansion of Duke-NUS’ Pathways to Medicine programme lets more aspiring doctors pursue diverse academic interests before joining medical school....

Aurie Receives FDA De Novo Grant for Reusable Intermittent Catheter System

The FDA marketing authorisation establishes a new Class II device category for Aurie’s automated reusable no-touch intermittent urinary catheter system, with launch planned in Veterans Health Administration spinal cord injury hospitals later this year. ...

Becker’s Names Leap Distributors CEO Allen Mason to 2026 Great Leaders in Healthcare List

Mason has more than 25 years of experience in the medical device industry and more than a decade of executive-level healthcare leadership expertise...

Wenda Pharma’s NHWD-870 Receives China Breakthrough Therapy Designation for NUT Carcinoma

The NMPA designation advances NHWD-870 HCI, an oral BET inhibitor for advanced thoracic NUT carcinoma, following Phase II data showing anti-tumour activity and survival benefit in a rare, aggressive cancer with limited treatment options. ...

Avalere Health Expands Into Japan With Integrated Advisory, Medical and Marketing Offering

The Tokyo office will support Japanese biopharmaceutical companies across the product lifecycle, combining market access, medical, marketing and strategic consulting capabilities under the leadership of Junji Yokokawa. ...